Possibilities to increase the effectiveness of doxorubicin in cancer cells killing
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Possibilities to increase the effectiveness of doxorubicin in cancer cells killing
Authors
Keywords
-
Journal
DRUG METABOLISM REVIEWS
Volume 43, Issue 4, Pages 540-557
Publisher
Informa UK Limited
Online
2011-09-27
DOI
10.3109/03602532.2011.609174
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
- (2014) Tomáš Šimůnek et al. Pharmacological Reports
- Glutathione Transferases as Targets for Cancer Therapy
- (2012) Paolo Ruzza et al. Anti-Cancer Agents in Medicinal Chemistry
- Fullerene-Conjugated Doxorubicin in Cells
- (2010) Jia-Hui Liu et al. ACS Applied Materials & Interfaces
- Genomic-directed targeted therapy increases endometrial cancer cell sensitivity to doxorubicin
- (2010) Megan D. Indermaur et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Galactosylated α,β-poly[(2-hydroxyethyl)-L-aspartamide]-bound doxorubicin
- (2010) Xiaoyun Cheng et al. ANTI-CANCER DRUGS
- N,N-Dimethyl phytosphingosine sensitizes HL-60/MX2, a multidrug-resistant variant of HL-60 cells, to doxorubicin-induced cytotoxicity through ROS-mediated release of cytochrome c and AIF
- (2010) Byeong Mo Kim et al. APOPTOSIS
- Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression
- (2010) Sin Ho Kweon et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A synthetic cantharidin analog for the enhancement of doxorubicin suppression of stem cell-derived aggressive sarcoma
- (2010) Chao Zhang et al. BIOMATERIALS
- The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: Cell cycle modulation plus target enzyme up-regulation
- (2010) Zhi Wei Quan et al. BIOMEDICINE & PHARMACOTHERAPY
- Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein
- (2010) Ju-Hwa Kim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette Transporters
- (2010) Y.-j. Mi et al. CANCER RESEARCH
- 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1
- (2010) Olga Wesołowska et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dose escalation and pharmacokinetic study of AEZS-108 (AN-152), an LHRH agonist linked to doxorubicin, in women with LHRH receptor-positive tumors
- (2010) Günter Emons et al. GYNECOLOGIC ONCOLOGY
- Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways
- (2010) Tongsen Zheng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers
- (2010) Elena V. Batrakova et al. JOURNAL OF CONTROLLED RELEASE
- Novel Oxadiazole Analogues Derived from Ethacrynic Acid: Design, Synthesis, and Structure−Activity Relationships in Inhibiting the Activity of GlutathioneS-Transferase P1-1 and Cancer Cell Proliferation
- (2010) Xinmei Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phenylsulfonylfuroxans as Modulators of Multidrug-Resistance-Associated Protein-1 and P-Glycoprotein
- (2010) Roberta Fruttero et al. JOURNAL OF MEDICINAL CHEMISTRY
- Long-Acting Phosphodiesterase-5 Inhibitor Tadalafil Attenuates Doxorubicin-Induced Cardiomyopathy without Interfering with Chemotherapeutic Effect
- (2010) S. Koka et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Review: doxorubicin delivery systems based on chitosan for cancer therapy
- (2010) Mei Lin Tan et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Genipin-Induced Inhibition of Uncoupling Protein-2 Sensitizes Drug-Resistant Cancer Cells to Cytotoxic Agents
- (2010) Ryan J. Mailloux et al. PLoS One
- Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction
- (2010) A. Das et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effectiveness of oracin in enhancing the cytotoxicity of doxorubicin through the inhibition of doxorubicin deactivation in breast cancer MCF7 cells
- (2010) V. Hanušová et al. XENOBIOTICA
- Cardiomyocyte death in doxorubicin-induced cardiotoxicity
- (2009) Yi-Wei Zhang et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: A comparative study
- (2009) Sonia Aroui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function
- (2009) Chun-ling Dai et al. BIOCHEMICAL PHARMACOLOGY
- Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet™)
- (2009) R.C.F. Leonard et al. BREAST
- Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function
- (2009) Li-yang Tao et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231
- (2009) Sonia Aroui et al. CANCER LETTERS
- Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2
- (2009) Chun-ling Dai et al. CANCER LETTERS
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- Two Nonsynonymous Single Nucleotide Polymorphisms of Human Carbonyl Reductase 1 Demonstrate Reduced in Vitro Metabolism of Daunorubicin and Doxorubicin
- (2009) O. S. Bains et al. DRUG METABOLISM AND DISPOSITION
- Enhancement of doxorubicin concentration in the M5076 ovarian sarcoma cells by cucurbitacin E co-treatment
- (2009) Yasuyuki Sadzuka et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Differential metabolic responses to pluronic in MDR and non-MDR cells: A novel pathway for chemosensitization of drug resistant cancers
- (2009) Daria Yu. Alakhova et al. JOURNAL OF CONTROLLED RELEASE
- Interactions between the flavonoid biochanin A and P-glycoprotein substrates in rats: In vitro and in vivo
- (2009) Shuzhong Zhang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Aqueous Compatible Fullerene−Doxorubicin Conjugates
- (2009) Fushen Lu et al. Journal of Physical Chemistry C
- LH receptor gene expression is essentially absent in breast tumor tissue: Implications for treatment
- (2009) T. Martijn Kuijper et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance
- (2009) Zachary W. Veitch et al. Pharmacogenetics and Genomics
- NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance
- (2009) Zhenfeng Duan et al. PLoS One
- Dibenzocyclooctadiene lignans overcome drug resistance in lung cancer cells – Study of structure–activity relationship
- (2009) I. Slaninová et al. TOXICOLOGY IN VITRO
- Doxorubicin conjugated to d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS): Conjugation chemistry, characterization, in vitro and in vivo evaluation
- (2008) Na Cao et al. BIOMATERIALS
- Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives
- (2008) Alessandra Bisi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of a potent and selective inhibitor for human carbonyl reductase 1 from propionate scanning applied to the macrolide zearalenone
- (2008) Tobias J. Zimmermann et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1/2
- (2008) B H Y Yeung et al. BRITISH JOURNAL OF CANCER
- Genetic polymorphisms in the carbonyl reductase 3 geneCBR3 and the NAD(P)H:quinone oxidoreductase 1 geneNQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer
- (2008) Javier G. Blanco et al. CANCER
- Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU
- (2008) Lin-xi Shi et al. CANCER LETTERS
- The Mitochondrial Uncoupling Protein-2 Promotes Chemoresistance in Cancer Cells
- (2008) Z. Derdak et al. CANCER RESEARCH
- Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients
- (2008) Suman Lal et al. CANCER SCIENCE
- Reduction of doxorubicin and oracin and induction of carbonyl reductase in human breast carcinoma MCF-7 cells
- (2008) Martina Gavelová et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Flavonoids as inhibitors of human carbonyl reductase 1
- (2008) Magnus Carlquist et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Cardiac toxicity: old and new issues in anti-cancer drugs
- (2008) María Sereno et al. Clinical & Translational Oncology
- Carbonyl Reductase 1 Is a Predominant Doxorubicin Reductase in the Human Liver
- (2008) N. Kassner et al. DRUG METABOLISM AND DISPOSITION
- Sensitization by docosahexaenoic acid (DHA) of breast cancer cells to anthracyclines through loss of glutathione peroxidase (GPx1) response
- (2008) Sophie Vibet et al. FREE RADICAL BIOLOGY AND MEDICINE
- Seliciclib (CYC202, R-roscovitine) enhances the antitumor effect of doxorubicinin vivoin a breast cancer xenograft model
- (2008) Maria Virginia C.L. Appleyard et al. INTERNATIONAL JOURNAL OF CANCER
- 2(3)-Aryl-thio(oxy)-methylquinoxaline Derivatives: A New Class of P-Glycoprotein-Mediated Drug Efflux Inhibitors
- (2008) Antonio Carta et al. Medicinal Chemistry
- Naringenin Enhances the Anti-Tumor Effect of Doxorubicin Through Selectively Inhibiting the Activity of Multidrug Resistance-Associated Proteins but not P-glycoprotein
- (2008) Fa Yun Zhang et al. PHARMACEUTICAL RESEARCH
- Inhibition of Polymorphic Human Carbonyl Reductase 1 (CBR1) by the Cardioprotectant Flavonoid 7-monohydroxyethyl Rutoside (monoHER)
- (2008) Vanessa Gonzalez-Covarrubias et al. PHARMACEUTICAL RESEARCH
- The effect of flavonoid derivatives on doxorubicin transport and metabolism
- (2007) Radka Václavíková et al. BIOORGANIC & MEDICINAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now